Mylan finalizes $465M settlement over EpiPen billing lawsuit

Thursday, August 17, 2017 - 15:32 in Mathematics & Economics

Mylan, makers of the anti-allergy injector EpiPen, finalized a $465 million settlement with the federal government over allegations it over-billed Medicaid.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net